2024.07.25
PEIJIA MEDICAL'S LICENSING PARTNER, JENA···
Peijia Medical commented on the acquisition of JenaValve Technology, Inc. ("JenaValve"), a···
2024.06.21
Peijia Medical Announced Proposed Share ···
On June 20, Peijia Medical announced that the Board resolved to repurchase shares of the Company in ···
2024.06.17
Peijia Medical Announced Audited 2023 An···
On June 16, Peijia Medical released the announcement of its audited results for the year ended Decem···
2024.06.11
Nearly a Hundred Investors and Analysts ···
In late May 2024, Peijia Medical successfully held its 2024 Corporate Day and the 4th Investor Day a···
2024.03.29
PEIJIA MEDICAL ANNOUNCED UNAUDITED 2023···
On March 28, 2024, Peijia Medical announced that it would delay the publication of 2023 annual resul···
2024.01.26
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATIN···
This announcement is made by Peijia Medical Limited (the “Company”, together with itssubsidiaries, t···
2023.10.31
Peijia Medical Presented Multiple Pipeli···
Transcatheter Cardiovascular Therapeutics 2023 (TCT 2023) conference, the annual scientific symposiu···
2023.07.24
UNAUDITED OPERATING STATISTICS FOR THE P···
2023.01.18
UNAUDITED OPERATING STATISTICS FOR THE P···
2022.04.06
Peijia Medical Announced 2021 Annual Res···
On March 31, 2022, Peijia Medical Limited (“Peijia Medical” or the “Company”, together with its subs···
2022.02.07
Peijia Medical Obtained Exclusive Licens···
Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in···
2021.08.31
Peijia Medical Announces 2021 Interim Re···
Peijia Medical Announces 2021 Interim ResultsTAVR products TaurusOne® and TaurusElite® lau···
